Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

However, admission to an intensive care unit to receive intravenous insulin infusion increases health care costs. A recent study proposes using a subcutaneous fast-acting analog of human insulin ...

Types of New Insulin Formulations: 1. Fast-acting insulin analogs: Faster onset, reduced hypoglycemia risk. 2.

Gan & Lee was first among all companies in procurement demand for insulin analogs in China's 2024 National Insulin-Specific Centralized Procurement, the company said in the release.

He undermines his argument, however, by stating that the newer, more expensive insulin analogs (such as Humalog and Novolog) are more effective than the older, cheaper insulins. Mr. Bradwel also ...

Diabetes. 2014;63(5):1779-1788. On the other hand, when mice were administered with equimolar INS or ProINS as ProINS-Tf, BG levels rapidly decreased within the first 2 h and then quickly returned ...

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...

Objective—Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...